Zobrazeno 1 - 10
of 273
pro vyhledávání: '"Daniel R. Couriel"'
Autor:
Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert Peter Gale, Betty K. Hamilton, Navneet S. Majhail, Alison W. Loren
Publikováno v:
Blood Advances, Vol 2, Iss 9, Pp 1022-1031 (2018)
Abstract: Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with
Externí odkaz:
https://doaj.org/article/eb6763f7bff54d2a9f6cf9c3ac09fd21
Autor:
Andrew C. Harris, Carrie L. Kitko, Daniel R. Couriel, Thomas M. Braun, Sung W. Choi, John Magenau, Shin Mineishi, Attaphol Pawarode, Gregory Yanik, John E. Levine
Publikováno v:
Haematologica, Vol 98, Iss 2 (2013)
Extramedullary relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia is a contributor to post-transplant mortality but risk factors for, and outcomes of, this condition are not well characterized. We analyzed 257
Externí odkaz:
https://doaj.org/article/5e3aa676723a4299b6a4ad29e2158414
Autor:
Jason R. Westin, Rima M. Saliba, Marcos De Lima, Amin Alousi, Chitra Hosing, Muzaffar H. Qazilbash, Issa F. Khouri, Elizabeth J. Shpall, Paolo Anderlini, Gabriela Rondon, Borje S. Andersson, Richard Champlin, Daniel R. Couriel
Publikováno v:
Advances in Hematology, Vol 2011 (2011)
Patients with steroid-resistant acute graft versus host disease (aGVHD) have a dismal prognosis, with mortality rates in excess of 90%. We sought to identify a subgroup of patients less likely to benefit from initial therapy with corticosteroids as w
Externí odkaz:
https://doaj.org/article/10fdb3c57b0c4114b28a6826d6ee477b
Publikováno v:
Annals of Hematology.
Autor:
D. Pulanić, Nataliya Prokopenko Buxbaum, Joerg Halter, Joseph Pidala, Lori Henderson, Stefanie Sarantopoulos, Yoshihiro Inamoto, Amin M. Alousi, Ted Gooley, Steven Z. Pavletic, Kelli P. A. MacDonald, Vijaya Raj Bhatt, Corey Cutler, Daniel R. Couriel, Attilio Olivieri, Bruce R. Blazar, Sophie Paczesny, Paul J. Martin, Kirk R. Schultz, Aleksandr Lazaryan, Carrie L. Kitko, Hildegard Greinix, Stephanie J. Lee, Zachariah DeFilipp, Daniel Wolff, Robert Zeiser, Gérard Socié
Publikováno v:
Transplant Cell Ther
Positive results from recent clinical trials have significantly expanded current therapeutic options for patients with chronic graft-versus-host disease (GVHD). However, new insights into the associations between clinical characteristics of chronic G
Chimeric antigen receptor T-cell (CAR-T) therapy has significantly improved outcomes as treatment of refractory/relapsed (R/R) B-cell non-Hodgkin lymphoma (NHL). Several risk factors including CAR-T-related toxicities and their treatments often lead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6e1848c4ce03c79df74d615280f607b
https://doi.org/10.21203/rs.3.rs-1995396/v1
https://doi.org/10.21203/rs.3.rs-1995396/v1
Autor:
Andrew D. Trunk, Katherine Radwanski, Cheryl Heber, Ashley Taylor, FenFen Hsieh, Andrew Harris, Catherine J. Lee, John D. Phillips, Daniel R. Couriel
Publikováno v:
Transplantation and Cellular Therapy. 29:396.e1-396.e5
Autor:
P. Anderlini, David Marin, Rohtesh S. Mehta, Roy B. Jones, Muzaffar H. Qazilbash, Daniel R. Couriel, Kayo Kondo, U. Popat, Bethany J. Overman, Katy Rezvani, Issa F. Khouri, Betul Oran, Stefan O. Ciurea, Amin M. Alousi, Richard E. Champlin, Chitra Hosing, Gabriela Rondon, Elizabeth J. Shpall, Roland L. Bassett, Partow Kebriaei
Publikováno v:
Bone Marrow Transplantation. 56:1316-1324
Steroids remain the initial therapy for acute graft-vs.-host disease (AGVHD). Strategies to improve response and minimize steroid exposure are needed. We report results of a randomized, adaptive, Bayesian-designed, phase II trial of prednisone with o
Autor:
Catherine J. Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R. Spellman, Carrie Kitko, Margaret L. MacMillan, Joseph A. Pidala, Jeffery J. Auletta, Sherif M. Badawy, Neel Bhatt, Vijaya R. Bhatt, Jean-Yves Cahn, Zachariah DeFilipp, Miguel A. Diaz, Nosha Farhadfar, Shahinaz Gadalla, Robert P. Gale, Hasan Hashem, Shahrukh Hashmi, Peiman Hematti, Sanghee Hong, Nasheed M. Hossain, Yoshihiro Inamoto, Lazaros J. Lekakis, Dipenkumar Modi, Sager Patel, Akshay Sharma, Scott Solomon, Daniel R. Couriel
Publikováno v:
Transplantation and cellular therapy. 28(10)
Chronic graft-versus-host disease (cGVHD) occurs in up to 25% of children following allogeneic hematopoietic cell transplantation (HCT) and continues to be a major cause of late morbidity and poor quality of life among long-term survivors of pediatri
Autor:
Joe L. Hsu, Gowri Satyanarayana, Vincent T. Ho, Vijaya Raj Bhatt, Mohamed Kharfan Dabaja, Lenora A. Pluchino, Javier Bolanos Meade, Areej El-Jawahri, Jonathan A. Gutman, Ayman Saad, Julianna Roddy, Marco Mielcarek, Antonio Di Stasi, Mitchell E. Horwitz, Jonathan Moreira, Carlyn Rose C. Tan, Ryotaro Nakamura, Mark A. Schroeder, Alison W. Loren, George Chen, Jennifer L. Burns, Sarah Anand, Daniel R. Couriel, Mark B. Juckett, Dimitrios Tzachanis, Ryan Bookout, Marcos de Lima, Sergio Giralt, Yago Nieto
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:599-634
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal hematopoietic and immune function. HCT is classified as autologous or al